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PERANAN KELAJUAN GELOMBANG DENYUTAN SEBAGAI 
PENANDA KEPARAHAN PENYAKIT ARTERI 
KORONARI(PAK) DI KALANGAN PESAKIT LELAKI DALAM 
KAJIAN TUNGGAL BERPUSAT 
 
ABSTRAK 
 
Penyakit arteri koronari merupakan salah satu penyakit yang biasa ditemui diseluruh 
dunia hari ini.  Ia melibatkan 6.9 juta kematian setiap tahun dan merupakan punca 
utama kematian pramatang di Negara-negara membangun.  Terdapat banyak faktor 
risiko yang berkait dengan peningkatan risiko PAK seperti merokok, umur, DM, 
hiperkolesterolemia dan tekanan darah tinggi.  Diagnosis awal dan pencegahan PAK 
telah menggiatkan pencarian satu kaedah boleh harap 'noninvasive' untuk 
pengesanannya.  Salah satu ujian noninvasive untuk diagnosa PAK ialah pengesanan 
kekerasan arteri dengan mengukur kelajuan gelombang denyutan menggunakan mesin 
sphygmoCor®. 
 
Kajian ini bertujuan untuk menentukan peranan kelajuan gelombang denyutan sebagai 
penanda kekerasan PAK dan juga menetukan perkaitan antara PWV (pulse wave 
velocity) dan faktor risiko kardiovaskular lain.  Satu kajian silang yang melibatkan 92 
orang pesakit yang menjalani angiografi koronari di ICL HUSM di jalankan untuk 
penilaian disyaki berpenyakit arteri koronari.  Ketegangan arteri di nilai melalui 
kelajuan gelombang denyutan karotid-femoral menggunakan mesin sphygmoCor®. 
 xi
 
Keputusan kajian ini menunjukkan PWV pesakit dengan PAK lebih tinggi berbanding 
pesakit tanpa PAK (11.3 ± 0.9 vs 8.14 ± 1.25 m/s, p<0.05).  Apabila kekerasan PAK 
dinyatakan sebagai satu-, dua-, dan penyakit pelbagai saluran atau normal, terdapat 
perkaitan bererti antara kekerasan PAK dan PWV (p<0.05), faktor risiko bebas bererti 
PAK adalah umur dan jumlah kolesterol (p>0.05) dan berkait secara bebas dengan 
PAK.  PWV  berbeza secara bererti dengan kategori kekerasan PAK yang berbeza 
walaupun umur dan jumlah kolesterol mereka di kawal.  
 
Kesimpulannya, kekerasan arteri yang di ukur melalui PWV adalah faktor risiko 
bebas dan pelengkap kardiovaskular.  Pengukuran kekerasan aortik boleh dijadikan 
sebagai penanda kerosakan organ sistem arterial, menunjukkan pertambahan risiko 
untuk komplikasi kardiovaskular dan membantu mengenalpasti pesakit yang berisiko 
tinggi untuk PAK yang mungkin bermanfaat dari diagnostik yang lebih agresif dan 
strategi terapeutik.  
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THE ROLE OF PULSE WAVE VELOCITY AS A MARKER OF SEVERITY 
OF CORONARY ARTERY DISEASE (CAD) IN MALE PATIENTS IN A 
SINGLE CENTRE STUDY 
ABSTRACT 
 
 
Coronary artery disease (CAD) is one of the most common diseases in the world 
today, causing 6.9 million deaths worldwide each year, and is the leading cause of 
premature death in developed countries.  There are many risk factors associated with 
increased risk of CAD such as smoking, age, DM, hypercholesterolemia and 
hypertension.  Early diagnosis and prevention of CAD have stimulated a search for 
reliable noninvasive methods of detection.  One of the noninvasive test to diagnose 
CAD is the detection of arterial stiffness by measuring pulse wave velocity using the 
sphygmoCor® machine.  This technique is valid, reproducible and widely applied. 
 
The aims of this study was to determine the role of pulse wave velocity (PWV) as a 
marker of the severity of CAD as well as to determine the association between PWV 
with other cardiovascular risk factors.  A cross sectional study with 92 patients 
undergoing coronary angiography in ICL HUSM for the assessment of suspected 
coronary artery disease was carried out. Arterial stiffness was assessed through left 
carotid – right femoral pulse wave velocity using automated SphygmoCor® machine. 
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The results of this study showed that PWV was higher in patients with CAD than 
those without CAD (11.13 ± 0.91 vs 8.14 ± 1.25 m/s, p < 0.001).  When the severity 
of CAD was expressed as single-, two- and multiple-vessel diseases, there was 
significant association between the severity of CAD and PWV (p < 0.05).  The 
significant independent risk factors of CAD were age and total cholesterol (P < 0.05) 
whereas smoking, BMI, SBP, DBP and DM were not significant (P > 0.05).  PWV 
differed significantly with different categorical severity of CAD even when their age 
and total cholesterol were controlled (P < 0.05).   
 
In conclusion, PWV is an independent and complementary cardiovascular risk factor. 
Measuring aortic stiffness should serve as marker of end organ damage regarding the 
arterial system, indicating an increased risk for cardiovascular complications, and 
helps to identify patients at high risk of CAD who may benefit from more aggressive 
diagnostic as well as therapeutic strategies. 
 
 
 
 
 
 
 
  
 
 
 
 
 
CHAPTER 1 - INTRODUCTION 
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1.1 Incidence of coronary artery disease.  
Coronary artery disease (CAD) is a disease of the coronary arteries, most commonly caused 
by atherosclerosis (Jamrozik, 2001).  Atherosclerosis is the thickening or hardening of the 
artery walls, formed by a combination of damage to the endothelial lining, the deposition 
and accumulation of cholesterol, and the development of atherosclerotic plaques within the 
walls, which advance in size gradually over time and narrow the vessel lumen (Rogers and 
Sharp, 1997; Tegos et al, 2001 and Mathur, 2002).  This process develops over many years, 
eventually causing the complete obstruction of coronary blood flow if left untreated 
(Davidson, 2000, Mathur, 2002 and Fox, 2002). Other non-coronary manifestations of 
atherosclerosis include stroke, peripheral vascular disease and aortic aneurysm. 
CAD is one of the most common diseases in the world today, causing 6.9 million deaths 
worldwide each year, and is the leading cause of premature death in developed countries 
(Mathur, 2002 and Australian Institute of Health and Welfare,  2003). In developing 
countries such as Malaysia, CAD may not be the number one cause of death at the moment.  
However, it has been estimated that by year 2020, there will be tremendous changes in 
disease pattern and demography that CAD will be the main cause of death in these 
countries (Murray et al, 1997).  Over the past three to four decades, there has been a 
phenomenal progress in the understanding of this disease due to the considerable rapport 
between basic scientists, clinicians, epidemiologists, communities as well as governments 
in an effort to overcome this modern scourge of the human race.  This has led to remarkable 
successes in not only treating the disease but also preventing it altogether or controlling its 
natural history (Marmot, 1985).  However, the battle is not yet over and for some countries, 
it is perhaps just beginning (Braunwald, 1997; Yusoff, 2000). 
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Mortality statistics of Peninsula Malaysia for the period 1950-1989 have been studied in 
relation to cardiovascular diseases, with particular emphasis on coronary artery disease as 
an important cause of death.  It was observed that among six major disease groups 
reviewed, cardiovascular diseases which occupied third place as a cause of death in 1950 
emerged as the number one killer during the 1970s and has remained so since then (with 
exception in 1980) (Khoo, 1995). 
 
The United Kingdom (and in particular Scotland and Northern Ireland) has one of the 
highest death rates in the world from CAD, while rates in Japan and the Mediterranean 
countries of Europe; such as Greece was low (Tunstall et al, 2000 and Lawlor et al, 2001). 
The incidence of CAD is also alarmingly high.  Each year, an estimated 700,000 Americans 
will have a new coronary attack. In addition, about 500,000 Americans will have a 
recurrent attack.  Among those who had myocardial infarction, 25 percent of men and 38 
percent of women are expected to die within one year. 
 
In spite of the unique fact that 50 percent of Indians are life long vegetarians, they have the 
highest incidence of coronary artery disease in the world.  Presently in India about 25 
million (estimated) people are suffering from heart disease. In England, Asian men and 
women are 40 percent more likely to die of heart disease compared to the local population. 
In the USA, Indians are 4 times more likely to die of heart disease compared to the 
American counterparts and 10 times more likely to die of this disease compared to the 
Japanese (Narinder and Saini, 2006). 
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1.2 The risk factors of CAD. 
 
Numerous coronary risk factors have been identified, some modifiable, others not. No 
doubt many more risk factors will be identified in the coming years as the current milieu of 
coronary risk factors cannot entirely account for the occurrence of CAD.  Their eradication 
in specific community is necessary as it can prevent the onslaught of the disease, or their 
control can reduce the consequence of the disease on individual patients.  Identification of 
coronary risk factors cannot be a finished business. Yet in Malaysia, perhaps caught on the 
onslaught of the disease, too much attention is given to treating (sometimes with minimal 
scientific basis) and too little to prevention.  This is ´´fire-fighting´´ with no strategic 
planning.  It is in this setting that the unwavering efforts by the National Heart Foundation 
of Malaysia through its Heart Week programmes deserve applause. These programmes 
serve to arouse the awareness and perhaps interest in the population on their health, in 
particular in relation to heart disease (Yusoff, 2000).   
 
It has been well documented that diabetes mellitus, smoking, hypertension and 
dyslipidemia are major risk factors for CAD.  However epidemiologic and experimental 
data suggest that activation of the renin-angiotensin-aldosterone system also has an 
important role in increasing the risk of cardiovascular events (Lonn et al, 1994).  The 
established major risk factors amenable to changes are smoking, high blood pressure, high 
serum cholesterol and diet (Stamler, 1992). 
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Table 1.1 Risk factors for coronary artery disease (CAD) (Barker, 2003) 
Fixed factors Exposure Composite markers of risk 
Age 
Gender 
Family history 
Race of origin 
Genotype 
Smoking 
Physical activity 
Diet 
Psychosocial stress 
In utero experience 
Infection 
Climatic factors (e.g high 
altitude) 
Serum lipids 
Blood pressure 
Obesity 
Insulin resistance 
Hormonal status 
Homocysteine 
 
1.2.1 Age: 
Age is the strongest risk indicator for CAD incidence and mortality (Lioyd-Jones et al, 
1999).  Compared to men aged 40, 50 year-old-men have five times the risk, 60 years-old-
men have 15 times the risk, and 70 years-old-men have over 40 times the risk of dying 
from CAD.  With aging there is a gradual but progressive accumulation of coronary 
plaques. This accounts for the increasing risk of CAD with advancing age (Scott, 1999).  
With aging, the aorta and predominantly elastic central arteries dilate; develop thicker walls 
and stiffer arteries.  These changes are progressive from adolescence.  However, changes in 
peripheral muscular arteries are far less marked compared to aorta (O’Rourke, 1994).  
Stiffening and dilatation of the aorta and elastic arteries with age in human is due to 
breakdown in the arrangement of musculo-elastic fascicles in the media of the vessels wall 
(O’Rourke, 1987).  These changes occur independently of atherosclerosis and are seen in 
the absence of significant atherosclerosis (Avolio et al, 1983).   
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The primary changes appear to be in the elastin fibers and lamellae.  The vessel walls 
thicken with age, mainly due to intima hyperplasia.  Elastic arteries in older subjects show 
the same number of musculo-elastic fascicles, but elastin fibers are thinned and fractured.  
There is an increase in collagen and other fibers together with increase in intercellular 
matrix (Virmani et al, 1991).  In older subjects, areas of cystic and medial necrosis are 
frequently seen in the arterial wall, with complete breakdown in the structural arrangement 
compared to the young (Eagle and Sanctis, 1992).  
 
1.2.2 Gender: 
Rates of death attributed to CAD in men are consistently three to four times higher than 
those in women across countries with differing background level of disease (Mathur and 
Gajanayake, 1998).  As the disease is commoner in men the differences in absolute risk are 
much greater for men than for women.  Men are more likely to smoke than women, but 
difference in smoking and other established coronary risk factor levels do not appear to 
fully explain the observed excess of CAD in men.  The lower risk of CAD among women 
has understandably led to studies of sex hormones as potential protective effect for CAD.  
It has often been stated that women are only protected against CAD before the menopause, 
and that their risk progressively increases towards that of men after the menopause (Hulley, 
1998).   
 
1.2.3 Family history and genetic factors: 
A family history of CAD in first-degree relatives is associated with an increased risk of 
CAD over and above that produced by a shared environment (Bennett, 1996).  The family 
history of CAD is a well-known risk factor in atherosclerosis, and therefore CAD 
 7
development; a family history of familial hypercholesteremia increases the risk.  
Familial hypercholesteremia is an inherited disorder, which causes a series of mutations in 
LDL receptors so that they no longer function, causing an excessive amount of LDL 
cholesterol to be present in the circulation that leads to atherosclerosis and increase risk of 
CAD (Jairath, 1999). 
 
1.2.4 Diet: 
Certain regional dietary patterns are associated with low risk of CAD, for example the 
Mediterranean diet, which contains more fish, fresh fruit, fresh vegetables, and olive oil 
than the English diet (Willett, 1994).  One small, randomized trial allocated people with a 
recent myocardial infarction to receive either advice to eat a Mediterranean diet (more 
bread, more vegetables, more fruit, more fish, and less meat) and to replace butter and 
cream with rapeseed margarine, or to usual dietary advice.  After 27 months the trial was 
stopped early because there was a marked reduction in the relative risk of death in those 
given advice to eat Mediterranean diet.  Of particular interest is the observation that these 
dietary changes did not alter blood cholesterol levels, implying that the protective effect 
was not mediated through an effect on cholesterol (Egger, 1998).  Moreover, cohort studies 
consistently reported a protective association between increased intake of dietary fibers 
from cereals and reduced rates of CAD (Keys et al, 1986).  
 
1.2.5 Smoking: 
Since the results of prospective epidemiological studies in the 1950s it has been clear that 
heavy cigarette smokers have an approximately two-fold increase in risk of CAD incidence 
and death, which is reduced by giving up the use of cigarettes, the risk returning to close to 
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that of non-smokers after about 10 years (Prescoh, 1998 and Edwavdis, 2000).  Smoking 
accounts for some of the international variation in CAD rates, but it is noticeable that some 
countries with a high prevalence of smoking, such as Japan, have low CAD rates (National 
Physical Activity Survey, 1999).  This is borne out by data from the MONICA study that 
found that smoking alone (when included in models that adjust for cholesterol and blood 
pressure) accounts for only 5 percent of the variance in rates of death attributed to CAD 
across countries (Peterson et al, 1999).  It is estimated that exposure to second hand smoke 
(passive smoking) causes almost 40000 deaths from heart disease each year in the United 
State (Elantz and Parmly, 1995), and increases the risk of coronary disease and coronary 
death by approximately 20% (Wells, 1994).  Smoking is associated with adverse effects on 
serum lipids which include elevation of triglyceride (TG) and reduction of high density 
lipoprotein (HDL), formation of proatherogenic oxidized particles. Also it leads to 
activation of sympathetic nervous system, enhanced prothrombotic state and endothelial 
dysfunction (James, 2001). 
In large study of middle-aged men in the United States, smokers in the highest quintiles for 
serum total cholesterol and systolic blood pressure were around 20 times as likely to die 
from CAD over the next 11.6 years as non-smokers in the lowest quintiles of serum 
cholesterol and blood pressure (Tunstall, 1999). 
 
1.2.6 Obesity: 
For nearly 100 years insurance data have demonstrated that very obese individual have an 
increase risk of death, including death from heart disease. Obesity is at least partially 
related to higher CAD risk because it is in turn associated with higher blood pressure and 
an unfavourable blood lipid profile (high low density lipoprotein (LDL) cholesterol and 
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lower high density lipoprotein (HDL) cholesterol).  Low levels of physical activity and a 
high caloric intake to physical activity ratio are particular implicated in the rising 
prevalence of obesity (National Physical Activity Survey, 1999).  The distribution of body 
fat may also play a role in development of CAD, with abdominal adiposity posing a 
substantially greater risk in both women and men (Wells AJ, 1994). Weight reduction 
programmes that include a structured exercise component should be considered in primary 
prevention for all obese (BMI>30kg/m²) patients and in most over weight (BMI>25 kg/m²) 
patients with a history of CAD (Michael, 2001). 
 
1.2.7 Insulin resistance and diabetes mellitus: 
A spectrum of metabolic disorder running from frank diabetes to minor level of glucose 
intolerance is of relevance when considering CAD risk.  Examining fasting glucose levels 
or glucose levels after standardized intake (e.g. in glucose tolerance test) demonstrates this, 
with some what arbitrary cut-offs being used for “impaired glucose tolerance (IGT)” and 
type 2 diabetes mellitus (T2DM) (Law et al, 1994).  This is not the case with type 1 
diabetes mellitus (T1DM), where in most instances people either have or have not the 
disease, but this is a considerably rare condition that contributes substantially less to the 
population levels of CAD than T2DM and IGT (Prospective diabetes study group, 1998). 
A cluster of physiological risk factors for CAD have been grouped into the insulin 
resistance syndrome (also known as the metabolic syndrome or syndrome X).  These 
involve resistance to insulin-stimulated glucose uptake, high circulating levels of insulin, 
high triglycerides levels, low HDL cholesterol level, and elevated blood pressure (Robert, 
1995). 
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The most important environmental factor influencing diabetes risk and level of glucose 
intolerance is obesity, in particular central obesity.  Physical activity also appears to protect 
against T2DM and IGT (National Physical Activity Survey, 1998).   
Unlike other risk factors such as circulating blood cholesterol or blood pressure, fasting 
glucose does not show a continuous association with CAD risk in prospective 
epidemiological studies.  Only 5 to 10 per cent of the population with high fasting glucose 
levels are associated with risk of CAD in studies in the United States and United Kingdom.  
Thus, the use of fasting glucose as a mean of predicting risk in individual is limited (Jarrett, 
1996).  
1.2.8 Physical activity: 
In the early days of the CAD epidemic in industrialized countries it was thought that 
exercise may predispose to CAD through cardiac strain.  However, research starting in the 
mid-twenty century suggested that occupational physical activity was associated with 
reduced risk of CAD.  With the increasing sedentary nature of many occupations this has 
become a less important risk factor for CAD and attention has shifted to physical activity in 
leisure time (Berlin  and Colditz, 1990).  
Physical activity results in increased exercise capacity and physical fitness, which may lead 
to many health benefits.  Individuals who are more physically active appear to have lower 
rates of all-cause mortality, probably due to a decrease in chronic diseases, including CAD. 
This low rate may result from an improvement in cardiovascular risk factors, as it helps in 
control of blood cholesterol, diabetes and obesity, as well as help to lower blood pressure, 
enhanced fibrinolysis, improved endothelial function and decreased sympathetic tone 
(Lowensteyn et al, 2000). 
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1.2.9 Stress: 
Stress is widely considered by the general public to be an important cause of CAD.  Indeed, 
several surveys of lay beliefs have shown that it is one of the most widely recognized risk 
factors for the disease.  People with little control over their work (e.g. shift workers in a 
factory) are; almost by definition; in less favorable social situation than those with greater 
control over their work (e.g. managers or senior academics) (Harding, 1995). 
 
1.2.10 Cholesterol: 
Circulating blood cholesterol is strongly and positively associated with CAD (Rosenson, 
1998 and Michael, 2001).  A series of large-scale, randomized, controlled trials of blood 
cholesterol reduction demonstrate that this process is reversible and risk reduction of the 
magnitude predicted from the observational data can be produced through lowering blood 
cholesterol (Rosenson, 1998).  It has been shown that lowering serum cholesterol by 10 
percent reduces the risk of CAD death by 15 percent (Guld et al, 1998).  Treatment for 
more than 5 years yields a 25 percent reduction in CAD events, thus, long term compliance 
is important for successful intervention (Law, 1994). 
 
One issue not directly relevant to CAD that led to controversy regarding cholesterol 
reduction was the suspicion that low circulating blood cholesterol caused an increased risk 
of morbidity and mortality from non-coronary causes, including cancer, psychiatric disease, 
and gastrointestinal and respiratory diseases.  Observational studies tended to report inverse 
association between blood cholesterol and these conditions, though it was clear that these 
associations could be generated through early stages of ill-health or adverse health-related 
behaviours leading to lower circulating cholesterol levels.  Finding from randomized 
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controlled trials of cholesterol reduction were initially ambiguous, in that there was 
evidence of elevation of non-coronary morbidity and mortality in some studies.  This now 
appear to reflect specific adverse effects of certain cholesterol lowering drugs, in particular 
the fibrates.  More recent studies in which circulating cholesterol levels were reduced more 
profoundly than in earlier studies, through the use of statins, suggest there are no 
detrimental effects of cholesterol lowering itself (Graham, 1997 and Farnier, 1998).  
 
Based on the evidence provided by recent clinical studies, the benefits provided by statins 
cannot be fully explained by their cholesterol lowering effects alone, and that other factors 
must be involved (Nissen, 2004).  The pleiotropic effects of statins include antithrombotic 
actions, an increase in fibrinolysis, anti-inflammatory effects, and a decrease in smooth 
muscle cell proliferation and migration (Pierre-Paul and Gahtan, 2003). 
 
Familial hypercholesterolaemia is an important condition illustrating the impact of raised 
serum lipids on the incidence of coronary artery disease; the monozygotes tend to get artery 
disease early with myocardial infarctions in their teens or early twenties (Brown et al, 
1986).  A number of mutations of the gene encoding for the LDL receptor proteins have 
been identified (Hobbs et al, 1992). 
 
1.2.11 Blood pressure (BP): 
There is a strong, consistent dose-response relationship between increased casual blood 
pressure measured in middle age and increased risk of CAD.  The effects on arterial 
stiffness: the first effect is functional and reversible, the second effect is structural and 
irreversible (Nicholas and O’Rourke, 1990).  The first affects all arteries (both elastic and 
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muscular), while the second, as with aging, has its greatest effect on the aorta and elastic 
arteries.  The central arteries pulsate greatly and are principally responsible for cushioning 
function of the arterial tree.  Long standing hypertension accelerates arterial degeneration.  
The aging changes occur prematurely in hypertensive subjects and are attributable to the 
same process.  High strains on the arterial wall results in fracture of elastin fibers and 
lamella occurring at an earlier age than in normotensive subjects.  The aorta and elastic 
arteries of patients with chronic hypertension are stiffer than in normotensive controls, even 
when measured at the same distending pressure (Ting et al, 1990). Systolic blood 
pressure(SBP) is at least as powerful a coronary risk factor as the diastolic blood 
pressure(DBP) in increasing risk of CAD and isolated systolic hypertension is now 
established as a major hazard for CAD and stroke (Wilking, 1988).  The excess coronary 
risk associated with hypertension is primarily in subgroups with other risk factors or 
underlying target organ damage.  These patients benefit the most from antihypertensive 
therapy.  An enhanced risk for cardiovascular events also appears to be associated with 
increase in pulse pressure (Wilson, 2001). 
In observational studies a 10 mmHg increase in diastolic blood pressure is associated with a 
37 per cent increase in the risk of CAD.  Large, randomized trials of pharmacological blood 
pressure reduction in middle age confirmed that blood pressure reduction reduce 
subsequent risk of CAD (Collins, 1990).  Several observational studies have also shown 
that increased blood pressure in early adult life, suggesting that risk trajectory may be set 
early.  Blood pressure is continuously distributed in population and increase in blood 
pressure across the range of blood pressure measures are associated with increased risk of 
CAD (Rose, 1992). 
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Blood pressure is determined both by environmental factors, such as increased sodium 
intake (increase blood pressure); increased alcohol intake (increase blood pressure); 
increased fruit and vegetables intake (lower blood pressure), and genetic factors.  While 
individual blood pressure response to environmental factors may be influenced by genetic 
factors, migrant studies illustrate the substantial and relatively rapidly acting effect of 
environmental factors.  In one study of migrants from a rural community in Western Kenya 
to urban Nairobi, mean diastolic blood pressure increased by around 6-10 mmHg from that 
measured previously (Powles, 1996).    
 
1.2.12 Haemostatic factors:   
Over the last 20 years a number of cohort studies have examined the association between 
haemostatic factors and CAD.  There is a consistent, independent association between 
increased fibrinogen levels and increased risk of CAD (Heinrich, 1995).  The subsequent 
risk of CAD comparing those in the highest third with those in the lowest third of the 
fibrinogen distribution at base line is increased by around 80 per cent (Sweetman, 1996).  
Some prospective studies have reported increased coronary risk with factors VII and VIII 
but the data are less extensive and less consistent (Scarabin, 1998).  Other studies have 
reported association with tissue-type plasminogen activator (t-PA) and with plasminogen 
activator inhibitor-1 (PAI-1); while platelet function tests do not appear to predict 
subsequent coronary risk (Naito, 1990).  Smokers have higher fibrinogen levels than non-
smokers and this may in part explain their excess coronary risk.  Fibrinogen levels are also 
associated with higher levels of other acute phase reactants suggesting that chronic 
inflammatory or infective processes may increase fibrinogen levels and thus risk of 
symptomatic CAD (Rosenson, 1993).  Increase fibrinogen level and high C-reactive protein 
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(CRP) are associated independently with a variety of cardiovascular end points in 
unhealthy and apparently healthy patients.  Fibrinogen is involved directly in coagulation, 
and CRP is a sensitive marker of inflammation and tissue damage.  In patients with stable 
angina, fibrinogen and CRP levels are predictors of cardiac events.  A CRP level of at least 
3 mg per L (28.6 nmol per L) predicts more ischemic episodes and the need for 
revascularization procedures; fibrinogen also has prognostic value in this circumstance 
(Sadovesky, 2004).  CRP has prognostic utility in patients with acute coronary syndromes 
and is a strong independent predictor of future coronary events in apparently healthy 
subjects (Rifai and Ridker, 2001). 
 
1.2.13 Homocysteine: 
Homocystinuria refers to a group of rare inborn errors of metabolism resulting in high 
levels of circulating homocysteine (10µmol per liter) and urinary homocysteine. A 
characteristic feature in patients with this condition is premature vascular disease.  If 
homocystinuria is untreated, about 50 percent of patients have thromboembolic events, and 
mortality is about 20 percent before the age of 30 years (Mudd et al, 1985). 
Observations in patients with homocystinuria led to the idea that homocysteine may be 
involved in the pathogenesis of atherosclerosis and prompted a large number of 
epidemiologic studies of the relation between moderately elevated Homocysteine levels 
and vascular disease (Verhoef and Stampfer, 1995 and Brattström, 1996). 
 
Elevated plasma homocysteine is a risk factor for CAD, but the prognostic value of 
homocysteine levels in patients with established CAD has not been defined (Glueck et al, 
1995 and Soinio et al 2004). 
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1.3 Confirmatory tests to diagnose CAD: 
The emphasis on early diagnosis and prevention of ischemic heart disease has stimulated a 
search for reliable noninvasive methods of detection (Epstein, 1971; Moore, 1971 and 
Friedberg, 1973).  Risk factor screening and resting electrocardiography (ECGs) are useful 
in epidemiologic and mass screening programmes but are not diagnostically helpful in the 
asymptomatic subject. Although exercise electrocardiography is widely used as a 
noninvasive procedure to diagnose CAD, the large proportion of false-positive and false-
negative results precludes its use as a standard screening device in the asymptomatic person 
(Borer et al, 1975; Redwood et al, 1976 and Froelicher et al, 1977).  Clinical or laboratory 
markers that might identify those with asymptomatic coronary artery disease would be 
useful.  Previous reports have established the positive relationship between the presence of 
coronary calcification on fluoroscopy and angiographically demonstrated CAD in 
symptomatic patients (Oliver, 1964). 
Exercise stress testing, exercise Thallium 201 imaging, and coronary angiography are 
established methods of evaluating patients with suspected CAD.  In addition to providing 
diagnostic information, these tests have been shown to yield important prognostic 
information (Ladenheim et al, 1986 and Kaul et al, 1988). 
The standard electrocardiographic treadmill exercise test is an established clinical 
procedure for detecting and evaluating patients with coronary artery disease (Fortuin and 
Weiss, 1977).  As a diagnostic tool, however, the procedure is limited by the somewhat low 
sensitivity and specificity of electrocardiographic ST-segment depression as a marker of 
ischemia. Thus, when the procedure is used in a population with a low prevalence of 
disease, a very high false-positive rate is inevitably observed (Hartley, 1975). 
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1.3.1 Non-invasive tests: 
 
1.3.1.1 Electrocardiography (ECG): 
The electrocardiogram (ECG) is a graphic recording of the electrical potentials generated 
by the heart.  The signals detected by means of metal electrodes attached to the extremities 
and chest wall and are then amplified and recorded by the electrocardiograph.  The basic 
ECG waveform consists of three deflections termed P wave, QRS complex and T wave.  
The P wave is the surface electrocardiographic manifestation of atrial depolarization.  The 
QRS complex is the surface electrocardiographic manifestation of ventricular 
depolarization. The S-T segment and T wave represent ventricular myocardial 
repolarization. The atrial repolarization is indicated by the Ta wave, which is small, 
asymmetrical negative wave following the P wave, usually obscured by the QRS complex 
which occurs at the same time (Rowland, 1991). 
 
The clinical utility of the ECG derives from its immediate availability as a non-invasive, 
inexpensive, and highly versatile test.  In addition to its use in detecting arrhythmias, 
conduction disturbance, and myocardial ischemia, electrocardiography may reveal other 
findings related to life-threatening metabolic disturbances (e.g., hyperkalemia) or increased 
susceptibility to sudden cardiac death (e.g., QT prolongation syndromes).  An abnormal 
electrocardiogram increases the suspicion of significant CAD, but a normal result does not 
exclude it (Mintz et al, 2001). 
 
 
 
 18
1.3.1.2 Exercise ECG: 
The present-day use of the exercise stress electrocardiogram in the diagnosis of CAD (in 
the form of the graded-exercise stress test-GXT) has evolved as a result of numerous 
observations and development (Fletcher et al, 1995).  Although the exercise ECG may be 
used for several purposes, it is commonest in the diagnosis and assessment of CAD.  In this 
respect, however it is extremely important at the outset to recognize that the test has a 
significant false-negative rate, even in population with an appreciable prevalence of CAD, 
and that the false-negative rate may be unacceptably high in populations with a low 
prevalence.  The test is therefore of very limited value in screening low-risk, asymptomatic 
subjects. Most subjects who have undergone exercise stress testing as a screening 
procedure and who subsequently experience sudden cardiac death are found in retrospect to 
have had a normal exercise test result (Ellestad et al, 1996.). 
 
A meta-analysis of 147 consecutive studies involving a total of 24074 patients who had 
undergone both exercise stress testing and coronary angiography revealed sensitivity 
ranging from 23 to 100 per cent (mean 68) and specificity ranging from 17 to 100 per cent 
(mean 77).  In patients with multi-vessel coronary disease the sensitivity ranged from 40 to 
100 per cent (mean 81) and the specificity from 17 to 100 (mean 66).  For patients with 
single-vessel disease a positive GXT is most likely for lesions in the left anterior 
descending artery.  Patients with lesions in the circumflex artery are least likely to give a 
positive result while those with lesion in the right coronary artery occupying intermediate 
position (Chaitman, 1997). 
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Inevitably, a GXT carries a risk, but multiple studies have shown the risk to be remarkably 
low. In 1971 a survey of 73 medical centers summarized the risks in relation to 
approximately 170000 stress tests.  A total of 16 deaths were reported (Mortality rate 0.01 
per cent), and 0.04 per cent required admission within 24 hours because of arrhythmia or 
prolonged chest pain.  The risk is greater when the test is conducted after ischemic events 
(Ellestad et al, 1996 and Chaitman, 1997). 
 
1.3.2  Invasive tests: 
 
1.3.2.1 Stress Echocardiography: 
Stress Echocardiography can be used to detect occult CAD and predict cardiac risk, whilst 
the administration of contrast agents may allow visualization of myocardial perfusion.  
Imaging can be performed either during or immediately after exercise, but more commonly 
an intravenous infusion of dobutamine is used to mimic the cardiac response to exercise. 
Development of reversible systolic regional wall motion abnormalities suggests CAD and 
stress echo is used increasingly as a diagnostic test in patients with chest pain (Oh, 1999 
and Flachskampf et al, 2001). 
 
1.3.2.2 Myocardial perfusion imaging: 
Myocardial perfusion imaging is undertaken using an injection of a radiopharmaceutical 
agent that is taken up by the myocardium in proportion to the myocardial blood flow at the 
time of the injection and which remains in the myocardial cells during the period of the 
imaging.  Studies are performed both at rest and under stress, in order to evaluate differing 
regional perfusion in these two states.  The three compounds mainly used in current clinical 
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practice are Thallium201, technetium-99m-Cardiolite (sestamibi-MIBI), and technetium-
99m-Myoview (tetrofosmin) (Travin et al, 1999). 
In patients with known CAD the main indications include: 
1. Evaluating the functional significance of coronary stenosis detected by angiography. 
2. Assessment of the most significant functional stenosis in patients with multiple 
coronary lesions; 
3. Evaluation of post infarction patients to establish the size of the infarct and the 
presence or absence of ischemia in other areas of the myocardium. 
It is also of value in the investigation of restenosis after revascularization with angioplasty 
or coronary artery bypass grafting (Rigo, 1998). 
1.3.2.3 Coronary artery angiography: 
Coronary arteriography or angiography is presently the single most essential application of 
cardiac catheterization.  The vast majority of patients presenting for cardiac catheterization 
have CAD.  Angiography of the coronary arteries performed during cardiac catheterization 
is essential for patients in whom revascularization is indicated.  Coronary angiography is 
indicated for patients having chronic stable angina that persist in spite of reasonable efforts 
at pharmacological therapy. It is also indicated for patients whose survival would be 
improved, regardless of symptoms.  Such patients are those with severe stenosis of the 
main left coronary artery and those with severe two-and three-vessels CAD in combination 
with impaired left ventricular function. Depending upon the availability of emergency 
revascularization, patients having acute myocardial infarction may be best served by 
immediate catheterization.  Finally, catheterization is sometimes indicated for obtaining a 
definitive diagnosis when non-invasive testing has yielded equivocal or inconsistent results 
(Baim et al, 2000).  
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1.4 Arterial stiffness: 
The blood vessels represent the largest structure in the body.  It consists of a complex 
network of branching elastic tubes, which at its arterial origin receives blood in spurts from 
the heart and transmits it downstream to the arterioles, capillaries, venules and veins before 
returning to the heart. 
 
The mechanical properties of the artery are dependant on its structure.  Arteries are divided 
histologically into three layers; the innermost layer is tunica intima, intermediate layer is 
tunica media and the outermost layer tunica adventitia. The tunica intima consists of 
endothelial cell layer, sub-endothelial connective tissue layer and the elastic tissue layer 
(internal elastic membrane).  The tunica media is composed of smooth muscle fibers and 
variable amount of collagen and elastic tissue.   
 
The mechanical properties of arteries depend on the tunica media which consist of elastic 
fibers, collagen fibers and smooth muscles.  At low level of pressure within the artery, the 
mechanical load is borne predominantly by the elastic fibers that are readily stretchable.  As 
the pressure increase, the collagen fibers are progressively recruited and arterial wall 
stiffness increase.  Therefore, at high pressure, the collagen fibers are fully recruited and 
the artery behaves as though it was composed of collagen alone (Glagov et al, 1992).   
 
The mechanical properties of elastic and collagen fibers are modified by smooth muscle in 
the arterial wall.  Muscle contraction and increase in tone transfer stress from elastic to the 
collagen fibers, making the arterial wall stiffer, whereas decrease in muscular tone unloads 
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the collagen fibers and transfers stress back to the elastic fibers so that the artery appears to 
be more complaint and less stiff (Gow, 1980).  The endothelium plays an important 
physiologic modulator of arterial smooth muscle tone.  Release of endothelial 
vasoconstrictor and dilator substances provide an important local control mechanism that is 
modulated by reflex and hormonal influences that change with age and disease.  
 
The arterial system has two functions: first is to act as a conduit, transmitting blood to 
tissue according to need; second is to act as a cushion, smoothing the pulsation imposed by 
intermittent cardiac ejection so that flow through the tissues occurs in a steady continuous 
stream (O'Rourke, 1982).  Disorder of the cushioning function like arterial stiffness has the 
effect on the heart upstream. 
 
Arterial stiffness is a part of endothelial dysfunction and therefore it explained the various 
associations and represents a valuable predicator of cardiovascular disease (Weber et al, 
2003).  There are several independent risk factors associated with arterial stiffness; these 
include male gender, hypertension, diabetes mellitus, hypercholesterolemia, increasing age, 
CAD, atherosclerosis, renal failure and cerebro-vascular disease (Nicole et al, 2001). 
Arterial stiffness is also correlated with atherosclerosis, probably through the effects of 
cyclic stress on arterial wall thickening.  There are several possible explanations for the 
observed association between arterial stiffness and atherosclerosis that can be hypothesized.  
One possibility is that presence of atherosclerosis leads to stiffening of the arteries.  An 
alternative possibility is that increased arterial stiffness leads to vessel wall damage and 
atherosclerosis.  A third possibility is that both mechanisms apply and that atherosclerosis 
is not a consequence of arterial stiffness but in advance stages also increase arterial stiffness 
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(Nicole et al, 2001).  In subjects with and without cardiovascular disease, arterial stiffness 
correlates with diastolic blood pressure, heart rate, height and gender. 
 
Arterial stiffness is a cause of premature return of reflected waves in late systole, increasing 
central pulse pressure (PP) and the load on the ventricle, reducing ejection fraction, and 
increasing myocardial oxygen demand.  Arterial stiffness is associated with left ventricular 
hypertrophy, a known risk for coronary events, in normotensive and hypertensive patients.  
Stiffening of the arterial tree leads to an increased systolic blood pressure and 
simultaneously a decreased diastolic blood pressure (London and Guerin, 1999).  The 
increased systolic blood pressure has a negative effect on the heart due to increased 
workload, while a reduced diastolic blood pressure may limit coronary perfusion, therefore 
will lead to myocardial ischemia.  The effect may explain the association between arterial 
stiffness and myocardial infarction (MI), as observed in cross-sectional studies (Benetos et 
al, 1997; Millar, 1999).  Increased arterial stiffness is also a risk factor for stroke 
(Domanski et al, 1999; Somes et al, 1999). 
 
Arterial stiffness may predict CAD beyond classical risk factors (Benetos et al, 1997; 
Millar, 1999).  Aortic stiffness was determined from carotid-femoral pulse wave velocity at 
baseline in 1045 hypertensive.  The risk assessment of CAD was made by calculating the 
Framingham risk score according to the categories of gender, age, blood pressure, 
cholesterol, diabetes, and smoking. Framingham score significantly predicted the 
occurrence of coronary and all cardiovascular events in this population (P<0.01 and 
P<0.0001, respectively). In a multivariate analysis, pulse wave velocity remained 
significantly associated with the occurrence of coronary event after adjustment either of 
 24
Framingham score (for 3.5 m/s: relative risk, 1.34; 95% CI, 1.01 to 1.79; P=0.039) or 
classic risk factors (for 3.5 m/s: relative risk, 1.39; 95% CI, 1.08 to 1.79; P=0.01) (Pierre et 
al, 2002).  
 
There are several different methods of assessing arterial stiffness, such as  pulse pressure, 
pulse wave velocity (PWV), waveform analysis, ultrasound derived indices and magnetic 
resonance imaging (MRI) derived indices. 
 
1.5 Role of pulse wave velocity: 
The pulse wave velocity is the speed at which the forward pressure wave is transmitted 
from the aorta through the vascular tree.  It is calculated by measuring the time taken for 
the arterial waveform to pass between two points a measured distance apart, and involves 
taking readings from the two sites simultaneously, or gating separate recordings to a fixed 
point in the cardiac cycle, usually the R wave of the ECG.  Various different methods have 
been used, both invasive and non-invasive, and can be applied to either flow or pressure 
waves.  
Problems with this technique include the inaccessibility of the central arteries, necessitating 
compromise by using the nearest superficial arteries.  There can also be some difficulty in 
estimating the actual arterial distance between recording sites using only surface 
measurements.  The pulse wave velocity becomes less accurate if the recording points are 
very close together, and the technique is, therefore, limited to use on the larger arteries. 
PWV is affected by respiratory variability.  This is because respiration modifies the intra-
thoracic pressure, the vessel wall tension and arterial blood pressure.  For this reason, the 
